Search Results for "Mallinckrodt Oxycodone 30mg"
Original Source: OXYCODONE HYDROCHLORIDE [Mallinckrodt, Inc.]
OXYCODONE HYDROCHLORIDETablets USP CII 5 mg, 15 mg, & 30 mg Rx only
Matching Channels
OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...
Covidien is the 9th largest global medical device company with annual sales in 2010 of almost $8 billion. Covidien was originally Tyco Healthcare, until June 2007, and has seen year-on-year growth s...
Matching News
FDA Oxycodone Enforcement Built On Difference Between “Same” And “Identical”
Companies must stop manufacturing unapproved single-ingredient, immediate-release oxycodone products in oral dosage forms within 45 days; FDA rejects Lannett petition, saying it has not provided evide...
Study finds reformulated ER Oxycodone abuse rates are significantly lower than original ER Oxycodone
(Inflexxion, Inc.) Aims of this study were to assess 1) whether the rates of abuse of extended-release (ER) oxycodone (OxyContin) decline following introduction of reformulated ER oxycodone (ORF), and...
SAN DIEGO, June 7, 2012 (GLOBE NEWSWIRE) -- Zogenix Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain...
Type: Original PaperPurposeTo understand the relationship between the risk of opioid-related gastrointestinal adverse effects (AEs) and exposure to tapentadol and oxycodone as well as its active metab...
Oxycodone Formula Change Blamed for Rise in Heroin Use
A change in a formula of the prescription opioid oxycodone to prevent abuse has had the unintended consequence of doubling heroin use among addicts. Medscape Medical News
FDA is dragging its feet over oxycodone generics
The US patent for Purdue Pharma’s (Purdue’s) blockbuster painkiller OxyContin (oxycodone) expired on 16 April 2013, but FDA has yet to approve any generic versions. Now, FDA has announced that it...
First transdermal oxycodone nears Phase III as Phosphagenics cues up next opioid target
With formulation issues for its lead therapeutic product now resolved, Phosphagenics looks set to apply for the approval of a pivotal clinical program for its first-in-class transdermal oxycodone prod...
15 Charged in Colorado for Oxycodone Ring
The Colorado Attorney General's Office announced on Thursday that it has charged 15 individuals of operating a prescription drug ring that involved fraudulently acquiring, diverting and distributing l...
Matching PubMed Articles
Anomalous observations of hydrocodone in patients on oxycodone.
BACKGROUND: Urine drug monitoring is used by physicians treating chronic pain patients with opioid therapy. Patients are tested in part to insure that they are not taking other drugs. Therefore, the f...
Summary Oxycodone's respiratory profile (particularly the extent of respiratory depression in comparison to morphine) remains to be fully characterised in the peri-operative period. We randomly assign...
Objectives: This exploratory study in healthy volunteers investigated the effect of single doses of oxycodone on gastrointestinal (GI) transit time and the degree to which a single dose of naloxone re...
PURPOSE: The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active oxymorphone. We performed a t...
OBJECTIVE: Oxycodone is widely used for the treatment of cancer pain, but little is known of its pharmacokinetics in cancer pain patients. The aim of this study was to explore the relationships betwee...
